Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial)
2018-001650-98Phase 3Unknown
- Sponsor
- University of Edinburgh
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine and clonidine in critical illness and Oversedation (3 arms), sponsored by University of Edinburgh. Primary endpoint: Time to successful extubation post-randomisation. Status: unknown.
02
Drugs
dexmedetomidineclonidine
03
Conditions
critical illnessOversedation
Beyond the preview
Go deeper on 2018-001650-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001650-98.